Biosimilars: Key market research findings The America’s dominate the market geographically Retail pharmacies account for a majority of the market revenue Key vendors – Sandoz, Hospira, Teva Pharmaceuticals, STADA, Biocon, Celltrion, and Dr. Reddy’s Technavio’s market research analysts predict the global market for biosimilars to showcase tremendous growth between 2016 and 2020. The…
Hypercholesterolemia drugs: key market research findings The Americas dominate the market geographically Statins account for a majority share of the market’s revenue Key vendors – AstraZeneca, Merck, Pfizer, Aegerion Pharmaceuticals, AbbVie, and Sanofi Technavio’s market research analysts predict the global hypercholesterolemia drugs market to grow at a CAGR of around 7% between 2016 and…
Monoclonal antibodies: Key market research findings The Americas dominate the market geographically Oncology segment accounts for a majority of the market’s revenue Key vendors – bbVie, F. Hoffmann-La Roche, Johnson & Johnson, Amgen, Merck, and BMS Technavio’s market research analysts predict the global mAbs market to grow at a CAGR of around 10% between…
Catheter stabilization devices: Key market research findings Americas dominate the market geographically PIVCs account for majority of the market’s revenue Key vendors – 3M, BD, C.R. Bard, and TIDI Products Technavio’s market research analysts predict the global catheter stabilization market to grow at a CAGR of more than 8% between 2016 and 2020. Catheter-related…
rhEPO in China: Key market research findings Perseverance of CKD and dialysis patient population drives market growth HIV segmentto exhibit the fastest growth rate during the forecast period Key vendors – 3S Bio, Shanghai Chemo, Chengdu Di’ao, NCPC Genentech, Kyowa Hakko Kirin, and Shandong Kexing Technavio’s market research analysts predict the rhEPO market in…
Generic drugs: Key market research findings Patent-expiry during the forecast period to drive market growth Increase in the number of M&As and strategic alliances Key vendors—Teva Pharmaceuticals, Sandoz, Allergan, Mylan, Sun Pharmaceuticals, and STADA Arzneimittel Technavio’s market research analysts predict the global generic drugs market to grow at a CAGR of almost 11% between…
Anticoagulants market: Key market research findings Novel oral anticoagulants (NOACs) to play a key role in the growth of the market Increase in the development of heparin drug in new therapeutic uses Key vendors in the anticoagulation market include Boehringer Ingelheim, BMS, Daiichi Sankyo, Johnson & Johnson, and Sanofi. Technavio’s market research analysts estimate…
Anticoagulants market: Key market research findings Novel oral anticoagulants (NOACs) to play a key role in the growth of the market Increase in the development of heparin drug in new therapeutic uses Key vendors in the anticoagulation market include Boehringer Ingelheim, BMS, Daiichi Sankyo, Johnson & Johnson, and Sanofi. Technavio’s market research analysts estimate…
Osteoarthritis pain: Key market research findings High unmet medical needs in the market Formation of strategic alliances between companies for development of drugs Key vendors in the market are Abbott Laboratories, Johnson & Johnson, Novartis, and Pfizer. Technavio’s market research analysts estimate the global osteoarthritis pain market to grow at a CAGR of over…
This market research report includes a detailed segmentation of the global non-alcoholic steatohepatitis market by dosage form (solid and liquid) and by route of administration (oral and parenteral). It also outlines the market shares for key regions like the Americas, APAC, and Europe. The leading vendors analyzed in this report are AstraZeneca, Arena Pharmaceuticals, GlaxoSmithKline,…
